隆海生物 (836344.OC)

+ 收藏

现金流量表(隆海生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 93,260,775.41153,662,729.66115,109,173.34223,142,401.5647,739,396.19
 收到的税费返还(元) -2,526,848.372,526,848.373,397,379.071,893,568.16
 收到其他与经营活动有关的现金(元) 1,046,262.931,126,817.95417,009.11813,005.15497,224.25
 经营活动现金流入小计(元) 94,307,038.34157,316,395.98118,053,030.82227,352,785.7850,130,188.60
 购买商品、接受劳务支付的现金(元) 58,681,640.34151,889,637.1397,462,779.25205,568,463.8147,026,022.24
 支付给职工以及为职工支付的现金(元) 1,070,168.392,284,325.641,136,882.122,335,287.491,098,847.87
 支付的各项税费(元) 1,995,473.595,774,745.515,256,326.985,585,745.063,231,931.51
 支付其他与经营活动有关的现金(元) 2,977,099.694,907,503.651,245,562.436,648,085.642,263,163.13
 经营活动现金流出小计(元) 64,724,382.01164,856,211.93105,101,550.78220,137,582.0053,619,964.75
 经营活动产生的现金流量净额(元) 29,582,656.33-7,539,815.9512,951,480.047,215,203.78-3,489,776.15
二、投资活动产生的现金流量
 收回投资收到的现金(元) 82,781.1417,010,000.00---
 取得投资收益收到的现金(元) -75,434.17---
 投资活动现金流入小计(元) 82,781.1417,085,434.17---
 购建固定资产、无形资产和其他长期资产支付的现金(元) 1,550,011.578,874,189.857,178,455.3029,268,742.814,806,491.93
 投资支付的现金(元) 92,778.8917,010,000.005,000,000.00--
 投资活动现金流出小计(元) 1,642,790.4625,884,189.8512,178,455.3029,268,742.814,806,491.93
 投资活动产生的现金流量净额(元) -1,560,009.32-8,798,755.68-12,178,455.30-29,268,742.81-4,806,491.93
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 102,662,500.0089,000,000.0076,100,000.0067,000,000.0041,050,000.00
 收到其他与筹资活动有关的现金(元) -10,000,000.00---
 筹资活动现金流入小计(元) 102,662,500.0099,000,000.0076,100,000.0067,000,000.0041,050,000.00
 偿还债务支付的现金(元) 86,767,500.0065,000,000.0054,000,000.0040,000,000.0022,423,422.00
 分配股利、利润或偿付利息支付的现金(元) 2,695,056.223,680,652.352,000,504.692,745,643.361,402,683.35
 支付其他与筹资活动有关的现金(元) 2,375,792.004,920,141.742,541,203.005,379,775.0063,655.32
 筹资活动现金流出小计(元) 91,838,348.2273,600,794.0958,541,707.6948,125,418.3623,889,760.67
 筹资活动产生的现金流量净额(元) 10,824,151.7825,399,205.9117,558,292.3118,874,581.6417,160,239.33
四、汇率变动对现金及现金等价物的影响(元) 98,104.78-27,550.49---
五、现金及现金等价物净增加额(元) 38,944,903.579,033,083.7918,331,317.05-3,178,957.398,863,971.25
 加:期初现金及现金等价物余额(元) 10,479,150.021,446,066.231,446,066.234,625,023.624,625,023.62
 期末现金及现金等价物余额(元) 49,424,053.5910,479,150.0219,777,383.281,446,066.2313,488,994.87
补充资料:
 净利润(元) 157,719.48-9,412,808.652,562,049.326,203,307.44675,017.66
 资产减值准备(元) -2,988,381.53---
 固定资产和投资性房地产折旧(元) 2,385,716.894,941,935.342,502,125.733,101,670.461,429,896.57
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 2,385,716.894,941,935.342,502,125.733,101,670.461,429,896.57
 无形资产摊销(元) 1,614,896.342,545,020.241,241,384.101,454,683.51617,737.80
 长期待摊费用摊销(元) 60,533.34141,066.7270,533.36134,044.4878,702.86
 处置固定资产、无形资产和其他长期资产的损失(元) --7,903.53--
 固定资产报废损失(元) -8,473.91---
 财务费用(元) 2,695,056.224,225,807.952,000,504.693,296,115.361,402,683.35
 投资损失(元) --75,434.17---
 存货的减少(元) 7,510,225.8527,040.34-542,955.533,573,916.75-10,439,589.06
 经营性应收项目的减少(元) 18,745,875.507,359,964.3222,078,320.26-14,351,470.291,476,983.58
 经营性应付项目的增加(元) -2,427,273.86-19,651,837.92-15,384,338.071,760,651.371,220,895.20
 现金的期末余额(元) 49,424,053.5910,479,150.0219,777,383.281,446,066.2313,488,994.87
 减:现金的期初余额(元) 10,479,150.021,446,066.231,446,066.234,625,023.624,625,023.62
 现金及现金等价物的净增加额(元) 38,944,903.579,033,083.7918,331,317.05-3,178,957.398,863,971.25
公告日期 2024-08-162024-04-182023-08-112023-04-252022-08-18
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院